Squamous cell carcinoma and MYH9-associated elastin aggregation (MALTA) syndrome
Squamous cell carcinoma and MYH9-associated elastin aggregation (MALTA) syndrome
About this course
- Released:
- Expires: December 7, 2028
Target Audience
This activity is intended for practicing dermatologists and other physicians involved in the treatment and management of diseases of the skin.
Learning Objective
To gain up-to-date knowledge of the genetic and clinical features of MYH9-associated elastin aggregation (MALTA) syndrome.
Accreditation and Designation Statement
Once the test is passed, a certificate of completion will be generated. The learning activity can be added to the Royal College of Physicians' CPD diary as a self-certified entry.
Activity Disclosures
No commercial support has been accepted related to the development or publication of this activity.